Why Sarepta Therapeutics’ Shares Rose 23.4% This Week

What happened
Shares of Sarepta Therapeutics (NASDAQ: SRPT) rose 24% this week as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The biotech company, which focuses on precision gene therapies, closed out at $123.06 a share last week, then ros

admin